These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 21699918)

  • 1. Identification of epitopes in Indian human papilloma virus 16 E6: a bioinformatics approach.
    Singh AK; Rath SK; Misra K
    J Virol Methods; 2011 Oct; 177(1):26-30. PubMed ID: 21699918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of epitopes and structural properties of Iranian HPV-16 E6 by bioinformatics methods.
    Mohabatkar H
    Asian Pac J Cancer Prev; 2007; 8(4):602-6. PubMed ID: 18260737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computer-aided analysis of structural properties and epitopes of Iranian HPV-16 E7 oncoprotein.
    Moosavi F; Mohabatkar H; Mohsenzadeh S
    Interdiscip Sci; 2010 Dec; 2(4):367-72. PubMed ID: 21153780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of promiscuous epitopes in the e6 protein of three high risk human papilloma viruses: a computational approach.
    Subramanian N; Chinnappan S
    Asian Pac J Cancer Prev; 2013; 14(7):4167-75. PubMed ID: 23991971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated E6 protein of human papillomavirus type 16 contains an unusual H-2Kb-restricted cytotoxic T cell epitope.
    Gao L; Walter J; Travers P; Stauss H; Chain BM
    J Immunol; 1995 Dec; 155(12):5519-26. PubMed ID: 7499833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins.
    Kast WM; Brandt RM; Sidney J; Drijfhout JW; Kubo RT; Grey HM; Melief CJ; Sette A
    J Immunol; 1994 Apr; 152(8):3904-12. PubMed ID: 7511661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of immunotherapeutic epitope of E5 protein of human papillomavirus-16: An in silico approach.
    Kumar A; Yadav IS; Hussain S; Das BC; Bharadwaj M
    Biologicals; 2015 Sep; 43(5):344-8. PubMed ID: 26212000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a naturally processed HLA A0201-restricted viral peptide from cells expressing human papillomavirus type 16 E6 oncoprotein.
    Bartholomew JS; Stacey SN; Coles B; Burt DJ; Arrand JR; Stern PL
    Eur J Immunol; 1994 Dec; 24(12):3175-9. PubMed ID: 7805746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Codon optimized expression of HPV 16 E6 renders target cells susceptible to E6-specific CTL recognition.
    Samorski R; Gissmann L; Osen W
    Immunol Lett; 2006 Sep; 107(1):41-9. PubMed ID: 16949679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.
    Ressing ME; Sette A; Brandt RM; Ruppert J; Wentworth PA; Hartman M; Oseroff C; Grey HM; Melief CJ; Kast WM
    J Immunol; 1995 Jun; 154(11):5934-43. PubMed ID: 7538538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human T-cell responses to HLA-A-restricted high binding affinity peptides of human papillomavirus type 18 proteins E6 and E7.
    Rudolf MP; Man S; Melief CJ; Sette A; Kast WM
    Clin Cancer Res; 2001 Mar; 7(3 Suppl):788s-795s. PubMed ID: 11300474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+ T cell immunity against the human papillomavirus-18 E6 transforming protein in healthy donors: identification of promiscuous naturally processed epitopes.
    Facchinetti V; Seresini S; Longhi R; Garavaglia C; Casorati G; Protti MP
    Eur J Immunol; 2005 Mar; 35(3):806-15. PubMed ID: 15719368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scanning the structure and antigenicity of HPV-16 E6 and E7 oncoproteins using antipeptide antibodies.
    Stacey SN; Eklund C; Jordan D; Smith NK; Stern PL; Dillner J; Arrand JR
    Oncogene; 1994 Feb; 9(2):635-45. PubMed ID: 7507231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicted epitopes of malarial merozoite surface protein 1 by bioinformatics method: a clue for further vaccine development.
    Wiwanitkit V
    J Microbiol Immunol Infect; 2009 Feb; 42(1):19-21. PubMed ID: 19424554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells.
    Feltkamp MC; Smits HL; Vierboom MP; Minnaar RP; de Jongh BM; Drijfhout JW; ter Schegget J; Melief CJ; Kast WM
    Eur J Immunol; 1993 Sep; 23(9):2242-9. PubMed ID: 7690326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicted epitopes of Lig A of Leptospira interrogans by bioinformatics method: a clue for further vaccine development.
    Wiwanitkit V
    Vaccine; 2007 Apr; 25(15):2768-70. PubMed ID: 17239493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease-stage variance in functional CD4(+) T-cell responses against novel pan-human leukocyte antigen-D region presented human papillomavirus-16 E7 epitopes.
    Warrino DE; Olson WC; Knapp WT; Scarrow MI; D'Ambrosio-Brennan LJ; Guido RS; Edwards RP; Kast WM; Storkus WJ
    Clin Cancer Res; 2004 May; 10(10):3301-8. PubMed ID: 15161683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity.
    Kenter GG; Welters MJ; Valentijn AR; Lowik MJ; Berends-van der Meer DM; Vloon AP; Drijfhout JW; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; van der Burg SH; Melief CJ
    Clin Cancer Res; 2008 Jan; 14(1):169-77. PubMed ID: 18172268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide engineering allows cytotoxic T-cell vaccination against human papilloma virus tumour antigen, E6.
    Lipford GB; Bauer S; Wagner H; Heeg K
    Immunology; 1995 Feb; 84(2):298-303. PubMed ID: 7751006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological responses in human papillomavirus 16 E6/E7-transgenic mice to E7 protein correlate with the presence of skin disease.
    Frazer IH; Leippe DM; Dunn LA; Liem A; Tindle RW; Fernando GJ; Phelps WC; Lambert PF
    Cancer Res; 1995 Jun; 55(12):2635-9. PubMed ID: 7540107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.